PMC:7354481 / 59037-60915 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T380","span":{"begin":178,"end":187},"obj":"Body_part"},{"id":"T381","span":{"begin":226,"end":230},"obj":"Body_part"},{"id":"T382","span":{"begin":286,"end":299},"obj":"Body_part"},{"id":"T383","span":{"begin":286,"end":297},"obj":"Body_part"},{"id":"T384","span":{"begin":314,"end":334},"obj":"Body_part"},{"id":"T385","span":{"begin":338,"end":351},"obj":"Body_part"},{"id":"T386","span":{"begin":338,"end":349},"obj":"Body_part"},{"id":"T387","span":{"begin":400,"end":408},"obj":"Body_part"},{"id":"T388","span":{"begin":419,"end":423},"obj":"Body_part"},{"id":"T389","span":{"begin":451,"end":464},"obj":"Body_part"},{"id":"T390","span":{"begin":491,"end":503},"obj":"Body_part"},{"id":"T391","span":{"begin":505,"end":514},"obj":"Body_part"},{"id":"T392","span":{"begin":527,"end":535},"obj":"Body_part"},{"id":"T393","span":{"begin":681,"end":689},"obj":"Body_part"},{"id":"T394","span":{"begin":690,"end":698},"obj":"Body_part"},{"id":"T395","span":{"begin":844,"end":847},"obj":"Body_part"},{"id":"T396","span":{"begin":897,"end":902},"obj":"Body_part"},{"id":"T397","span":{"begin":985,"end":999},"obj":"Body_part"},{"id":"T398","span":{"begin":985,"end":996},"obj":"Body_part"},{"id":"T399","span":{"begin":1022,"end":1035},"obj":"Body_part"},{"id":"T400","span":{"begin":1022,"end":1033},"obj":"Body_part"},{"id":"T401","span":{"begin":1040,"end":1054},"obj":"Body_part"},{"id":"T402","span":{"begin":1040,"end":1051},"obj":"Body_part"},{"id":"T403","span":{"begin":1125,"end":1134},"obj":"Body_part"},{"id":"T404","span":{"begin":1150,"end":1160},"obj":"Body_part"},{"id":"T405","span":{"begin":1445,"end":1456},"obj":"Body_part"},{"id":"T406","span":{"begin":1523,"end":1534},"obj":"Body_part"},{"id":"T407","span":{"begin":1570,"end":1581},"obj":"Body_part"}],"attributes":[{"id":"A380","pred":"fma_id","subj":"T380","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A381","pred":"fma_id","subj":"T381","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A382","pred":"fma_id","subj":"T382","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A383","pred":"fma_id","subj":"T383","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A384","pred":"fma_id","subj":"T384","obj":"http://purl.org/sig/ont/fma/fma9672"},{"id":"A385","pred":"fma_id","subj":"T385","obj":"http://purl.org/sig/ont/fma/fma264830"},{"id":"A386","pred":"fma_id","subj":"T386","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A387","pred":"fma_id","subj":"T387","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A388","pred":"fma_id","subj":"T388","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A389","pred":"fma_id","subj":"T389","obj":"http://purl.org/sig/ont/fma/fma9825"},{"id":"A390","pred":"fma_id","subj":"T390","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A391","pred":"fma_id","subj":"T391","obj":"http://purl.org/sig/ont/fma/fma83358"},{"id":"A392","pred":"fma_id","subj":"T392","obj":"http://purl.org/sig/ont/fma/fma12278"},{"id":"A393","pred":"fma_id","subj":"T393","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A394","pred":"fma_id","subj":"T394","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A395","pred":"fma_id","subj":"T395","obj":"http://purl.org/sig/ont/fma/fma67847"},{"id":"A396","pred":"fma_id","subj":"T396","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A397","pred":"fma_id","subj":"T397","obj":"http://purl.org/sig/ont/fma/fma264825"},{"id":"A398","pred":"fma_id","subj":"T398","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A399","pred":"fma_id","subj":"T399","obj":"http://purl.org/sig/ont/fma/fma264831"},{"id":"A400","pred":"fma_id","subj":"T400","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A401","pred":"fma_id","subj":"T401","obj":"http://purl.org/sig/ont/fma/fma264824"},{"id":"A402","pred":"fma_id","subj":"T402","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A403","pred":"fma_id","subj":"T403","obj":"http://purl.org/sig/ont/fma/fma241981"},{"id":"A404","pred":"fma_id","subj":"T404","obj":"http://purl.org/sig/ont/fma/fma241981"},{"id":"A405","pred":"fma_id","subj":"T405","obj":"http://purl.org/sig/ont/fma/fma82740"},{"id":"A406","pred":"fma_id","subj":"T406","obj":"http://purl.org/sig/ont/fma/fma82740"},{"id":"A407","pred":"fma_id","subj":"T407","obj":"http://purl.org/sig/ont/fma/fma82740"}],"text":"WikiPathways p-Adj\nPhotodynamic therapy-induced NF-kB survival signaling 0\nIL-18 signaling pathway 8.6 × 10−9\nmiRNAs involvement in the immune response in sepsis 2.4 × 10−8\nCytokines and Inflammatory Response 9.9 × 10−7\nLung fibrosis 2.5 × 10−6\nBioPlanet p-Adj\nOncostatin M 0\nInterleukin-1 regulation of extracellular matrix 0\nInterleukin-5 regulation of apoptosis 0\nTNF-alpha effects on cytokine activity, cell motility, and apoptosis 0\nImmune system signaling by interferons, interleukins, prolactin, and growth hormones 0\nKEGG p-Adj\nIL-17 signaling pathway 1.3 × 10−9\nTNF signaling pathway 1.6 × 10−9\nLegionellosis 3.5 × 10−9\nRheumatoid arthritis 5.4 × 10−9\nCytokine-cytokine receptor interaction 6.6 × 10−9\nPANTHER p-Adj\nPlasminogen activating cascade 0.00156\nToll receptor signaling pathway 0.00911\nCCKR signaling map ST 0.02550\nApoptosis signaling pathway 0.10282\nBlood coagulation 0.10433\nREACTOME p-Adj\nInterferon alpha/beta signaling 1.6 × 10−9\nInterleukin-10 signaling 2.5 × 10−9\nInterleukin-4 and Interleukin-13 signaling 2.4 × 10−7\nFormation of the cornified envelope 1.3 × 10−5\nChemokine receptors bind chemokines 0.00047\nSmall Molecule Pathway DB p-Adj\nCD40L Signalling Pathway 0.25268\nNF-kB Signaling Pathway 0.25268\nToll-Like Receptor Pathway 2 0.25268\nCapecitabine Metabolism Pathway 0.25268\nCapecitabine Action Pathway 0.25268\nBIOCYC p-Adj\nvitamin D3 biosynthesis 0.03597\nguanosine nucleotides degradation 0.03597\nretinoate biosynthesis II 0.03597\nguanosine nucleotides degradation III 0.03597\nadenosine nucleotides degradation II 0.03597\nPathway Interaction DB p-Adj\nValidated transcriptional targets of AP1 family members Fra1 and Fra2 3.8 × 10−5\nIL23-mediated signaling events 0.00050\nCD40/CD40L signaling 0.02539\nGlucocorticoid receptor regulatory network 0.02603\nLPA receptor mediated events 0.04171"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T72","span":{"begin":226,"end":230},"obj":"Body_part"},{"id":"T73","span":{"begin":451,"end":464},"obj":"Body_part"},{"id":"T74","span":{"begin":897,"end":902},"obj":"Body_part"}],"attributes":[{"id":"A72","pred":"uberon_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A73","pred":"uberon_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"A74","pred":"uberon_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"WikiPathways p-Adj\nPhotodynamic therapy-induced NF-kB survival signaling 0\nIL-18 signaling pathway 8.6 × 10−9\nmiRNAs involvement in the immune response in sepsis 2.4 × 10−8\nCytokines and Inflammatory Response 9.9 × 10−7\nLung fibrosis 2.5 × 10−6\nBioPlanet p-Adj\nOncostatin M 0\nInterleukin-1 regulation of extracellular matrix 0\nInterleukin-5 regulation of apoptosis 0\nTNF-alpha effects on cytokine activity, cell motility, and apoptosis 0\nImmune system signaling by interferons, interleukins, prolactin, and growth hormones 0\nKEGG p-Adj\nIL-17 signaling pathway 1.3 × 10−9\nTNF signaling pathway 1.6 × 10−9\nLegionellosis 3.5 × 10−9\nRheumatoid arthritis 5.4 × 10−9\nCytokine-cytokine receptor interaction 6.6 × 10−9\nPANTHER p-Adj\nPlasminogen activating cascade 0.00156\nToll receptor signaling pathway 0.00911\nCCKR signaling map ST 0.02550\nApoptosis signaling pathway 0.10282\nBlood coagulation 0.10433\nREACTOME p-Adj\nInterferon alpha/beta signaling 1.6 × 10−9\nInterleukin-10 signaling 2.5 × 10−9\nInterleukin-4 and Interleukin-13 signaling 2.4 × 10−7\nFormation of the cornified envelope 1.3 × 10−5\nChemokine receptors bind chemokines 0.00047\nSmall Molecule Pathway DB p-Adj\nCD40L Signalling Pathway 0.25268\nNF-kB Signaling Pathway 0.25268\nToll-Like Receptor Pathway 2 0.25268\nCapecitabine Metabolism Pathway 0.25268\nCapecitabine Action Pathway 0.25268\nBIOCYC p-Adj\nvitamin D3 biosynthesis 0.03597\nguanosine nucleotides degradation 0.03597\nretinoate biosynthesis II 0.03597\nguanosine nucleotides degradation III 0.03597\nadenosine nucleotides degradation II 0.03597\nPathway Interaction DB p-Adj\nValidated transcriptional targets of AP1 family members Fra1 and Fra2 3.8 × 10−5\nIL23-mediated signaling events 0.00050\nCD40/CD40L signaling 0.02539\nGlucocorticoid receptor regulatory network 0.02603\nLPA receptor mediated events 0.04171"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T327","span":{"begin":622,"end":635},"obj":"Disease"},{"id":"T328","span":{"begin":648,"end":668},"obj":"Disease"},{"id":"T329","span":{"begin":659,"end":668},"obj":"Disease"}],"attributes":[{"id":"A327","pred":"mondo_id","subj":"T327","obj":"http://purl.obolibrary.org/obo/MONDO_0005823"},{"id":"A328","pred":"mondo_id","subj":"T328","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A329","pred":"mondo_id","subj":"T329","obj":"http://purl.obolibrary.org/obo/MONDO_0005578"}],"text":"WikiPathways p-Adj\nPhotodynamic therapy-induced NF-kB survival signaling 0\nIL-18 signaling pathway 8.6 × 10−9\nmiRNAs involvement in the immune response in sepsis 2.4 × 10−8\nCytokines and Inflammatory Response 9.9 × 10−7\nLung fibrosis 2.5 × 10−6\nBioPlanet p-Adj\nOncostatin M 0\nInterleukin-1 regulation of extracellular matrix 0\nInterleukin-5 regulation of apoptosis 0\nTNF-alpha effects on cytokine activity, cell motility, and apoptosis 0\nImmune system signaling by interferons, interleukins, prolactin, and growth hormones 0\nKEGG p-Adj\nIL-17 signaling pathway 1.3 × 10−9\nTNF signaling pathway 1.6 × 10−9\nLegionellosis 3.5 × 10−9\nRheumatoid arthritis 5.4 × 10−9\nCytokine-cytokine receptor interaction 6.6 × 10−9\nPANTHER p-Adj\nPlasminogen activating cascade 0.00156\nToll receptor signaling pathway 0.00911\nCCKR signaling map ST 0.02550\nApoptosis signaling pathway 0.10282\nBlood coagulation 0.10433\nREACTOME p-Adj\nInterferon alpha/beta signaling 1.6 × 10−9\nInterleukin-10 signaling 2.5 × 10−9\nInterleukin-4 and Interleukin-13 signaling 2.4 × 10−7\nFormation of the cornified envelope 1.3 × 10−5\nChemokine receptors bind chemokines 0.00047\nSmall Molecule Pathway DB p-Adj\nCD40L Signalling Pathway 0.25268\nNF-kB Signaling Pathway 0.25268\nToll-Like Receptor Pathway 2 0.25268\nCapecitabine Metabolism Pathway 0.25268\nCapecitabine Action Pathway 0.25268\nBIOCYC p-Adj\nvitamin D3 biosynthesis 0.03597\nguanosine nucleotides degradation 0.03597\nretinoate biosynthesis II 0.03597\nguanosine nucleotides degradation III 0.03597\nadenosine nucleotides degradation II 0.03597\nPathway Interaction DB p-Adj\nValidated transcriptional targets of AP1 family members Fra1 and Fra2 3.8 × 10−5\nIL23-mediated signaling events 0.00050\nCD40/CD40L signaling 0.02539\nGlucocorticoid receptor regulatory network 0.02603\nLPA receptor mediated events 0.04171"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T707","span":{"begin":53,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0007074"},{"id":"T708","span":{"begin":53,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0051988"},{"id":"T709","span":{"begin":65,"end":74},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T710","span":{"begin":81,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T711","span":{"begin":84,"end":93},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T712","span":{"begin":226,"end":230},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T713","span":{"begin":226,"end":230},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T714","span":{"begin":286,"end":299},"obj":"http://purl.obolibrary.org/obo/PR_000001091"},{"id":"T715","span":{"begin":409,"end":423},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T716","span":{"begin":451,"end":464},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"T717","span":{"begin":465,"end":474},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T718","span":{"begin":505,"end":514},"obj":"http://purl.obolibrary.org/obo/PR_000013246"},{"id":"T719","span":{"begin":558,"end":567},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T720","span":{"begin":592,"end":601},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T721","span":{"begin":748,"end":759},"obj":"http://purl.obolibrary.org/obo/PR_000012867"},{"id":"T722","span":{"begin":760,"end":770},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T723","span":{"begin":802,"end":811},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T724","span":{"begin":834,"end":843},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T725","span":{"begin":848,"end":850},"obj":"http://purl.obolibrary.org/obo/CLO_0009141"},{"id":"T726","span":{"begin":848,"end":850},"obj":"http://purl.obolibrary.org/obo/CLO_0050980"},{"id":"T727","span":{"begin":870,"end":879},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T728","span":{"begin":897,"end":902},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T729","span":{"begin":897,"end":902},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T730","span":{"begin":963,"end":972},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T731","span":{"begin":985,"end":999},"obj":"http://purl.obolibrary.org/obo/PR_000001471"},{"id":"T732","span":{"begin":1000,"end":1009},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T733","span":{"begin":1055,"end":1064},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T734","span":{"begin":1193,"end":1195},"obj":"http://purl.obolibrary.org/obo/CLO_0002709"},{"id":"T735","span":{"begin":1210,"end":1220},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T736","span":{"begin":1241,"end":1243},"obj":"http://purl.obolibrary.org/obo/CLO_0007074"},{"id":"T737","span":{"begin":1241,"end":1243},"obj":"http://purl.obolibrary.org/obo/CLO_0051988"},{"id":"T738","span":{"begin":1244,"end":1253},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T739","span":{"begin":1410,"end":1412},"obj":"http://purl.obolibrary.org/obo/CLO_0002675"},{"id":"T740","span":{"begin":1626,"end":1628},"obj":"http://purl.obolibrary.org/obo/CLO_0002709"},{"id":"T741","span":{"begin":1733,"end":1742},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T742","span":{"begin":1770,"end":1779},"obj":"http://purl.obolibrary.org/obo/SO_0000418"}],"text":"WikiPathways p-Adj\nPhotodynamic therapy-induced NF-kB survival signaling 0\nIL-18 signaling pathway 8.6 × 10−9\nmiRNAs involvement in the immune response in sepsis 2.4 × 10−8\nCytokines and Inflammatory Response 9.9 × 10−7\nLung fibrosis 2.5 × 10−6\nBioPlanet p-Adj\nOncostatin M 0\nInterleukin-1 regulation of extracellular matrix 0\nInterleukin-5 regulation of apoptosis 0\nTNF-alpha effects on cytokine activity, cell motility, and apoptosis 0\nImmune system signaling by interferons, interleukins, prolactin, and growth hormones 0\nKEGG p-Adj\nIL-17 signaling pathway 1.3 × 10−9\nTNF signaling pathway 1.6 × 10−9\nLegionellosis 3.5 × 10−9\nRheumatoid arthritis 5.4 × 10−9\nCytokine-cytokine receptor interaction 6.6 × 10−9\nPANTHER p-Adj\nPlasminogen activating cascade 0.00156\nToll receptor signaling pathway 0.00911\nCCKR signaling map ST 0.02550\nApoptosis signaling pathway 0.10282\nBlood coagulation 0.10433\nREACTOME p-Adj\nInterferon alpha/beta signaling 1.6 × 10−9\nInterleukin-10 signaling 2.5 × 10−9\nInterleukin-4 and Interleukin-13 signaling 2.4 × 10−7\nFormation of the cornified envelope 1.3 × 10−5\nChemokine receptors bind chemokines 0.00047\nSmall Molecule Pathway DB p-Adj\nCD40L Signalling Pathway 0.25268\nNF-kB Signaling Pathway 0.25268\nToll-Like Receptor Pathway 2 0.25268\nCapecitabine Metabolism Pathway 0.25268\nCapecitabine Action Pathway 0.25268\nBIOCYC p-Adj\nvitamin D3 biosynthesis 0.03597\nguanosine nucleotides degradation 0.03597\nretinoate biosynthesis II 0.03597\nguanosine nucleotides degradation III 0.03597\nadenosine nucleotides degradation II 0.03597\nPathway Interaction DB p-Adj\nValidated transcriptional targets of AP1 family members Fra1 and Fra2 3.8 × 10−5\nIL23-mediated signaling events 0.00050\nCD40/CD40L signaling 0.02539\nGlucocorticoid receptor regulatory network 0.02603\nLPA receptor mediated events 0.04171"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43","span":{"begin":50,"end":52},"obj":"Chemical"},{"id":"T40205","span":{"begin":78,"end":80},"obj":"Chemical"},{"id":"T85801","span":{"begin":383,"end":388},"obj":"Chemical"},{"id":"T49332","span":{"begin":491,"end":503},"obj":"Chemical"},{"id":"T78269","span":{"begin":520,"end":535},"obj":"Chemical"},{"id":"T69867","span":{"begin":527,"end":535},"obj":"Chemical"},{"id":"T9718","span":{"begin":552,"end":554},"obj":"Chemical"},{"id":"T96062","span":{"begin":848,"end":850},"obj":"Chemical"},{"id":"T62064","span":{"begin":952,"end":957},"obj":"Chemical"},{"id":"T74514","span":{"begin":958,"end":962},"obj":"Chemical"},{"id":"T80070","span":{"begin":1185,"end":1192},"obj":"Chemical"},{"id":"T81989","span":{"begin":1221,"end":1228},"obj":"Chemical"},{"id":"T91246","span":{"begin":1238,"end":1240},"obj":"Chemical"},{"id":"T61187","span":{"begin":1254,"end":1261},"obj":"Chemical"},{"id":"T98824","span":{"begin":1290,"end":1297},"obj":"Chemical"},{"id":"T84779","span":{"begin":1333,"end":1340},"obj":"Chemical"},{"id":"T97841","span":{"begin":1363,"end":1369},"obj":"Chemical"},{"id":"T1497","span":{"begin":1370,"end":1377},"obj":"Chemical"},{"id":"T53481","span":{"begin":1402,"end":1412},"obj":"Chemical"},{"id":"T72741","span":{"begin":1402,"end":1409},"obj":"Chemical"},{"id":"T61528","span":{"begin":1435,"end":1444},"obj":"Chemical"},{"id":"T66639","span":{"begin":1445,"end":1456},"obj":"Chemical"},{"id":"T94256","span":{"begin":1478,"end":1487},"obj":"Chemical"},{"id":"T23098","span":{"begin":1501,"end":1503},"obj":"Chemical"},{"id":"T46810","span":{"begin":1513,"end":1522},"obj":"Chemical"},{"id":"T58030","span":{"begin":1523,"end":1534},"obj":"Chemical"},{"id":"T44793","span":{"begin":1560,"end":1569},"obj":"Chemical"},{"id":"T28161","span":{"begin":1570,"end":1581},"obj":"Chemical"},{"id":"T93154","span":{"begin":1594,"end":1596},"obj":"Chemical"},{"id":"T96820","span":{"begin":1606,"end":1613},"obj":"Chemical"},{"id":"T34427","span":{"begin":1674,"end":1677},"obj":"Chemical"}],"attributes":[{"id":"A88861","pred":"chebi_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/CHEBI_141424"},{"id":"A33873","pred":"chebi_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/CHEBI_25573"},{"id":"A71121","pred":"chebi_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/CHEBI_1224"},{"id":"A80416","pred":"chebi_id","subj":"T40205","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A49799","pred":"chebi_id","subj":"T40205","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A75614","pred":"chebi_id","subj":"T85801","obj":"http://purl.obolibrary.org/obo/CHEBI_30216"},{"id":"A16464","pred":"chebi_id","subj":"T49332","obj":"http://purl.obolibrary.org/obo/CHEBI_52998"},{"id":"A96082","pred":"chebi_id","subj":"T78269","obj":"http://purl.obolibrary.org/obo/CHEBI_37845"},{"id":"A2175","pred":"chebi_id","subj":"T69867","obj":"http://purl.obolibrary.org/obo/CHEBI_24621"},{"id":"A60992","pred":"chebi_id","subj":"T9718","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A28518","pred":"chebi_id","subj":"T9718","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A34490","pred":"chebi_id","subj":"T96062","obj":"http://purl.obolibrary.org/obo/CHEBI_141393"},{"id":"A42962","pred":"chebi_id","subj":"T62064","obj":"http://purl.obolibrary.org/obo/CHEBI_30216"},{"id":"A62523","pred":"chebi_id","subj":"T74514","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"},{"id":"A98991","pred":"chebi_id","subj":"T80070","obj":"http://purl.obolibrary.org/obo/CHEBI_34922"},{"id":"A86439","pred":"chebi_id","subj":"T81989","obj":"http://purl.obolibrary.org/obo/CHEBI_34922"},{"id":"A40999","pred":"chebi_id","subj":"T91246","obj":"http://purl.obolibrary.org/obo/CHEBI_141424"},{"id":"A54071","pred":"chebi_id","subj":"T91246","obj":"http://purl.obolibrary.org/obo/CHEBI_25573"},{"id":"A38545","pred":"chebi_id","subj":"T91246","obj":"http://purl.obolibrary.org/obo/CHEBI_1224"},{"id":"A2599","pred":"chebi_id","subj":"T61187","obj":"http://purl.obolibrary.org/obo/CHEBI_34922"},{"id":"A26902","pred":"chebi_id","subj":"T98824","obj":"http://purl.obolibrary.org/obo/CHEBI_34922"},{"id":"A39124","pred":"chebi_id","subj":"T84779","obj":"http://purl.obolibrary.org/obo/CHEBI_34922"},{"id":"A72718","pred":"chebi_id","subj":"T97841","obj":"http://purl.obolibrary.org/obo/CHEBI_5133"},{"id":"A95616","pred":"chebi_id","subj":"T1497","obj":"http://purl.obolibrary.org/obo/CHEBI_34922"},{"id":"A32914","pred":"chebi_id","subj":"T53481","obj":"http://purl.obolibrary.org/obo/CHEBI_28940"},{"id":"A36261","pred":"chebi_id","subj":"T72741","obj":"http://purl.obolibrary.org/obo/CHEBI_33229"},{"id":"A66921","pred":"chebi_id","subj":"T61528","obj":"http://purl.obolibrary.org/obo/CHEBI_16750"},{"id":"A32338","pred":"chebi_id","subj":"T66639","obj":"http://purl.obolibrary.org/obo/CHEBI_36976"},{"id":"A38827","pred":"chebi_id","subj":"T94256","obj":"http://purl.obolibrary.org/obo/CHEBI_139589"},{"id":"A87773","pred":"chebi_id","subj":"T94256","obj":"http://purl.obolibrary.org/obo/CHEBI_15036"},{"id":"A7247","pred":"chebi_id","subj":"T23098","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A14594","pred":"chebi_id","subj":"T46810","obj":"http://purl.obolibrary.org/obo/CHEBI_16750"},{"id":"A90783","pred":"chebi_id","subj":"T58030","obj":"http://purl.obolibrary.org/obo/CHEBI_36976"},{"id":"A17894","pred":"chebi_id","subj":"T44793","obj":"http://purl.obolibrary.org/obo/CHEBI_16335"},{"id":"A21134","pred":"chebi_id","subj":"T28161","obj":"http://purl.obolibrary.org/obo/CHEBI_36976"},{"id":"A7962","pred":"chebi_id","subj":"T93154","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A92131","pred":"chebi_id","subj":"T96820","obj":"http://purl.obolibrary.org/obo/CHEBI_34922"},{"id":"A63553","pred":"chebi_id","subj":"T34427","obj":"http://purl.obolibrary.org/obo/CHEBI_62519"}],"text":"WikiPathways p-Adj\nPhotodynamic therapy-induced NF-kB survival signaling 0\nIL-18 signaling pathway 8.6 × 10−9\nmiRNAs involvement in the immune response in sepsis 2.4 × 10−8\nCytokines and Inflammatory Response 9.9 × 10−7\nLung fibrosis 2.5 × 10−6\nBioPlanet p-Adj\nOncostatin M 0\nInterleukin-1 regulation of extracellular matrix 0\nInterleukin-5 regulation of apoptosis 0\nTNF-alpha effects on cytokine activity, cell motility, and apoptosis 0\nImmune system signaling by interferons, interleukins, prolactin, and growth hormones 0\nKEGG p-Adj\nIL-17 signaling pathway 1.3 × 10−9\nTNF signaling pathway 1.6 × 10−9\nLegionellosis 3.5 × 10−9\nRheumatoid arthritis 5.4 × 10−9\nCytokine-cytokine receptor interaction 6.6 × 10−9\nPANTHER p-Adj\nPlasminogen activating cascade 0.00156\nToll receptor signaling pathway 0.00911\nCCKR signaling map ST 0.02550\nApoptosis signaling pathway 0.10282\nBlood coagulation 0.10433\nREACTOME p-Adj\nInterferon alpha/beta signaling 1.6 × 10−9\nInterleukin-10 signaling 2.5 × 10−9\nInterleukin-4 and Interleukin-13 signaling 2.4 × 10−7\nFormation of the cornified envelope 1.3 × 10−5\nChemokine receptors bind chemokines 0.00047\nSmall Molecule Pathway DB p-Adj\nCD40L Signalling Pathway 0.25268\nNF-kB Signaling Pathway 0.25268\nToll-Like Receptor Pathway 2 0.25268\nCapecitabine Metabolism Pathway 0.25268\nCapecitabine Action Pathway 0.25268\nBIOCYC p-Adj\nvitamin D3 biosynthesis 0.03597\nguanosine nucleotides degradation 0.03597\nretinoate biosynthesis II 0.03597\nguanosine nucleotides degradation III 0.03597\nadenosine nucleotides degradation II 0.03597\nPathway Interaction DB p-Adj\nValidated transcriptional targets of AP1 family members Fra1 and Fra2 3.8 × 10−5\nIL23-mediated signaling events 0.00050\nCD40/CD40L signaling 0.02539\nGlucocorticoid receptor regulatory network 0.02603\nLPA receptor mediated events 0.04171"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T98","span":{"begin":159,"end":165},"obj":"Phenotype"},{"id":"T99","span":{"begin":648,"end":668},"obj":"Phenotype"}],"attributes":[{"id":"A98","pred":"hp_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/HP_0100806"},{"id":"A99","pred":"hp_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/HP_0001370"}],"text":"WikiPathways p-Adj\nPhotodynamic therapy-induced NF-kB survival signaling 0\nIL-18 signaling pathway 8.6 × 10−9\nmiRNAs involvement in the immune response in sepsis 2.4 × 10−8\nCytokines and Inflammatory Response 9.9 × 10−7\nLung fibrosis 2.5 × 10−6\nBioPlanet p-Adj\nOncostatin M 0\nInterleukin-1 regulation of extracellular matrix 0\nInterleukin-5 regulation of apoptosis 0\nTNF-alpha effects on cytokine activity, cell motility, and apoptosis 0\nImmune system signaling by interferons, interleukins, prolactin, and growth hormones 0\nKEGG p-Adj\nIL-17 signaling pathway 1.3 × 10−9\nTNF signaling pathway 1.6 × 10−9\nLegionellosis 3.5 × 10−9\nRheumatoid arthritis 5.4 × 10−9\nCytokine-cytokine receptor interaction 6.6 × 10−9\nPANTHER p-Adj\nPlasminogen activating cascade 0.00156\nToll receptor signaling pathway 0.00911\nCCKR signaling map ST 0.02550\nApoptosis signaling pathway 0.10282\nBlood coagulation 0.10433\nREACTOME p-Adj\nInterferon alpha/beta signaling 1.6 × 10−9\nInterleukin-10 signaling 2.5 × 10−9\nInterleukin-4 and Interleukin-13 signaling 2.4 × 10−7\nFormation of the cornified envelope 1.3 × 10−5\nChemokine receptors bind chemokines 0.00047\nSmall Molecule Pathway DB p-Adj\nCD40L Signalling Pathway 0.25268\nNF-kB Signaling Pathway 0.25268\nToll-Like Receptor Pathway 2 0.25268\nCapecitabine Metabolism Pathway 0.25268\nCapecitabine Action Pathway 0.25268\nBIOCYC p-Adj\nvitamin D3 biosynthesis 0.03597\nguanosine nucleotides degradation 0.03597\nretinoate biosynthesis II 0.03597\nguanosine nucleotides degradation III 0.03597\nadenosine nucleotides degradation II 0.03597\nPathway Interaction DB p-Adj\nValidated transcriptional targets of AP1 family members Fra1 and Fra2 3.8 × 10−5\nIL23-mediated signaling events 0.00050\nCD40/CD40L signaling 0.02539\nGlucocorticoid receptor regulatory network 0.02603\nLPA receptor mediated events 0.04171"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T297","span":{"begin":65,"end":74},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T298","span":{"begin":84,"end":101},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T299","span":{"begin":84,"end":93},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T300","span":{"begin":140,"end":155},"obj":"http://purl.obolibrary.org/obo/GO_0006955"},{"id":"T301","span":{"begin":192,"end":213},"obj":"http://purl.obolibrary.org/obo/GO_0006954"},{"id":"T302","span":{"begin":300,"end":310},"obj":"http://purl.obolibrary.org/obo/GO_0065007"},{"id":"T303","span":{"begin":352,"end":375},"obj":"http://purl.obolibrary.org/obo/GO_0042981"},{"id":"T304","span":{"begin":352,"end":362},"obj":"http://purl.obolibrary.org/obo/GO_0065007"},{"id":"T305","span":{"begin":366,"end":375},"obj":"http://purl.obolibrary.org/obo/GO_0097194"},{"id":"T306","span":{"begin":366,"end":375},"obj":"http://purl.obolibrary.org/obo/GO_0006915"},{"id":"T307","span":{"begin":400,"end":417},"obj":"http://purl.obolibrary.org/obo/GO_0005125"},{"id":"T308","span":{"begin":419,"end":432},"obj":"http://purl.obolibrary.org/obo/GO_0048870"},{"id":"T309","span":{"begin":438,"end":447},"obj":"http://purl.obolibrary.org/obo/GO_0097194"},{"id":"T310","span":{"begin":438,"end":447},"obj":"http://purl.obolibrary.org/obo/GO_0006915"},{"id":"T311","span":{"begin":465,"end":474},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T312","span":{"begin":520,"end":526},"obj":"http://purl.obolibrary.org/obo/GO_0040007"},{"id":"T313","span":{"begin":558,"end":575},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T314","span":{"begin":558,"end":567},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T315","span":{"begin":592,"end":609},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T316","span":{"begin":592,"end":601},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T317","span":{"begin":748,"end":770},"obj":"http://purl.obolibrary.org/obo/GO_0031639"},{"id":"T318","span":{"begin":802,"end":819},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T319","span":{"begin":802,"end":811},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T320","span":{"begin":834,"end":843},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T321","span":{"begin":860,"end":869},"obj":"http://purl.obolibrary.org/obo/GO_0097194"},{"id":"T322","span":{"begin":860,"end":869},"obj":"http://purl.obolibrary.org/obo/GO_0006915"},{"id":"T323","span":{"begin":870,"end":887},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T324","span":{"begin":870,"end":879},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T325","span":{"begin":897,"end":914},"obj":"http://purl.obolibrary.org/obo/GO_0007596"},{"id":"T326","span":{"begin":903,"end":914},"obj":"http://purl.obolibrary.org/obo/GO_0050817"},{"id":"T327","span":{"begin":963,"end":972},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T328","span":{"begin":1000,"end":1009},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T329","span":{"begin":1055,"end":1064},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T330","span":{"begin":1077,"end":1086},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T331","span":{"begin":1210,"end":1228},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T332","span":{"begin":1210,"end":1220},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T333","span":{"begin":1244,"end":1261},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T334","span":{"begin":1244,"end":1253},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T335","span":{"begin":1322,"end":1332},"obj":"http://purl.obolibrary.org/obo/GO_0008152"},{"id":"T336","span":{"begin":1402,"end":1425},"obj":"http://purl.obolibrary.org/obo/GO_1901755"},{"id":"T337","span":{"begin":1413,"end":1425},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T338","span":{"begin":1445,"end":1468},"obj":"http://purl.obolibrary.org/obo/GO_0009166"},{"id":"T339","span":{"begin":1457,"end":1468},"obj":"http://purl.obolibrary.org/obo/GO_0009056"},{"id":"T340","span":{"begin":1488,"end":1500},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T341","span":{"begin":1523,"end":1546},"obj":"http://purl.obolibrary.org/obo/GO_0009166"},{"id":"T342","span":{"begin":1535,"end":1546},"obj":"http://purl.obolibrary.org/obo/GO_0009056"},{"id":"T343","span":{"begin":1570,"end":1593},"obj":"http://purl.obolibrary.org/obo/GO_0009166"},{"id":"T344","span":{"begin":1582,"end":1593},"obj":"http://purl.obolibrary.org/obo/GO_0009056"},{"id":"T345","span":{"begin":1647,"end":1662},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T346","span":{"begin":1733,"end":1742},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T347","span":{"begin":1770,"end":1779},"obj":"http://purl.obolibrary.org/obo/GO_0023052"}],"text":"WikiPathways p-Adj\nPhotodynamic therapy-induced NF-kB survival signaling 0\nIL-18 signaling pathway 8.6 × 10−9\nmiRNAs involvement in the immune response in sepsis 2.4 × 10−8\nCytokines and Inflammatory Response 9.9 × 10−7\nLung fibrosis 2.5 × 10−6\nBioPlanet p-Adj\nOncostatin M 0\nInterleukin-1 regulation of extracellular matrix 0\nInterleukin-5 regulation of apoptosis 0\nTNF-alpha effects on cytokine activity, cell motility, and apoptosis 0\nImmune system signaling by interferons, interleukins, prolactin, and growth hormones 0\nKEGG p-Adj\nIL-17 signaling pathway 1.3 × 10−9\nTNF signaling pathway 1.6 × 10−9\nLegionellosis 3.5 × 10−9\nRheumatoid arthritis 5.4 × 10−9\nCytokine-cytokine receptor interaction 6.6 × 10−9\nPANTHER p-Adj\nPlasminogen activating cascade 0.00156\nToll receptor signaling pathway 0.00911\nCCKR signaling map ST 0.02550\nApoptosis signaling pathway 0.10282\nBlood coagulation 0.10433\nREACTOME p-Adj\nInterferon alpha/beta signaling 1.6 × 10−9\nInterleukin-10 signaling 2.5 × 10−9\nInterleukin-4 and Interleukin-13 signaling 2.4 × 10−7\nFormation of the cornified envelope 1.3 × 10−5\nChemokine receptors bind chemokines 0.00047\nSmall Molecule Pathway DB p-Adj\nCD40L Signalling Pathway 0.25268\nNF-kB Signaling Pathway 0.25268\nToll-Like Receptor Pathway 2 0.25268\nCapecitabine Metabolism Pathway 0.25268\nCapecitabine Action Pathway 0.25268\nBIOCYC p-Adj\nvitamin D3 biosynthesis 0.03597\nguanosine nucleotides degradation 0.03597\nretinoate biosynthesis II 0.03597\nguanosine nucleotides degradation III 0.03597\nadenosine nucleotides degradation II 0.03597\nPathway Interaction DB p-Adj\nValidated transcriptional targets of AP1 family members Fra1 and Fra2 3.8 × 10−5\nIL23-mediated signaling events 0.00050\nCD40/CD40L signaling 0.02539\nGlucocorticoid receptor regulatory network 0.02603\nLPA receptor mediated events 0.04171"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T450","span":{"begin":0,"end":20},"obj":"Sentence"},{"id":"T451","span":{"begin":21,"end":77},"obj":"Sentence"},{"id":"T452","span":{"begin":78,"end":113},"obj":"Sentence"},{"id":"T453","span":{"begin":114,"end":177},"obj":"Sentence"},{"id":"T454","span":{"begin":178,"end":225},"obj":"Sentence"},{"id":"T455","span":{"begin":226,"end":251},"obj":"Sentence"},{"id":"T456","span":{"begin":252,"end":269},"obj":"Sentence"},{"id":"T457","span":{"begin":270,"end":285},"obj":"Sentence"},{"id":"T458","span":{"begin":286,"end":337},"obj":"Sentence"},{"id":"T459","span":{"begin":338,"end":378},"obj":"Sentence"},{"id":"T460","span":{"begin":379,"end":450},"obj":"Sentence"},{"id":"T461","span":{"begin":451,"end":538},"obj":"Sentence"},{"id":"T462","span":{"begin":539,"end":551},"obj":"Sentence"},{"id":"T463","span":{"begin":552,"end":587},"obj":"Sentence"},{"id":"T464","span":{"begin":588,"end":621},"obj":"Sentence"},{"id":"T465","span":{"begin":622,"end":647},"obj":"Sentence"},{"id":"T466","span":{"begin":648,"end":680},"obj":"Sentence"},{"id":"T467","span":{"begin":681,"end":731},"obj":"Sentence"},{"id":"T468","span":{"begin":732,"end":747},"obj":"Sentence"},{"id":"T469","span":{"begin":748,"end":787},"obj":"Sentence"},{"id":"T470","span":{"begin":788,"end":828},"obj":"Sentence"},{"id":"T471","span":{"begin":829,"end":859},"obj":"Sentence"},{"id":"T472","span":{"begin":860,"end":896},"obj":"Sentence"},{"id":"T473","span":{"begin":897,"end":923},"obj":"Sentence"},{"id":"T474","span":{"begin":924,"end":940},"obj":"Sentence"},{"id":"T475","span":{"begin":941,"end":984},"obj":"Sentence"},{"id":"T476","span":{"begin":985,"end":1021},"obj":"Sentence"},{"id":"T477","span":{"begin":1022,"end":1076},"obj":"Sentence"},{"id":"T478","span":{"begin":1077,"end":1124},"obj":"Sentence"},{"id":"T479","span":{"begin":1125,"end":1169},"obj":"Sentence"},{"id":"T480","span":{"begin":1170,"end":1203},"obj":"Sentence"},{"id":"T481","span":{"begin":1204,"end":1237},"obj":"Sentence"},{"id":"T482","span":{"begin":1238,"end":1270},"obj":"Sentence"},{"id":"T483","span":{"begin":1271,"end":1308},"obj":"Sentence"},{"id":"T484","span":{"begin":1309,"end":1349},"obj":"Sentence"},{"id":"T485","span":{"begin":1350,"end":1386},"obj":"Sentence"},{"id":"T486","span":{"begin":1387,"end":1401},"obj":"Sentence"},{"id":"T487","span":{"begin":1402,"end":1434},"obj":"Sentence"},{"id":"T488","span":{"begin":1435,"end":1477},"obj":"Sentence"},{"id":"T489","span":{"begin":1478,"end":1512},"obj":"Sentence"},{"id":"T490","span":{"begin":1513,"end":1559},"obj":"Sentence"},{"id":"T491","span":{"begin":1560,"end":1605},"obj":"Sentence"},{"id":"T492","span":{"begin":1606,"end":1636},"obj":"Sentence"},{"id":"T493","span":{"begin":1637,"end":1718},"obj":"Sentence"},{"id":"T494","span":{"begin":1719,"end":1758},"obj":"Sentence"},{"id":"T495","span":{"begin":1759,"end":1788},"obj":"Sentence"},{"id":"T496","span":{"begin":1789,"end":1840},"obj":"Sentence"},{"id":"T497","span":{"begin":1841,"end":1878},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"WikiPathways p-Adj\nPhotodynamic therapy-induced NF-kB survival signaling 0\nIL-18 signaling pathway 8.6 × 10−9\nmiRNAs involvement in the immune response in sepsis 2.4 × 10−8\nCytokines and Inflammatory Response 9.9 × 10−7\nLung fibrosis 2.5 × 10−6\nBioPlanet p-Adj\nOncostatin M 0\nInterleukin-1 regulation of extracellular matrix 0\nInterleukin-5 regulation of apoptosis 0\nTNF-alpha effects on cytokine activity, cell motility, and apoptosis 0\nImmune system signaling by interferons, interleukins, prolactin, and growth hormones 0\nKEGG p-Adj\nIL-17 signaling pathway 1.3 × 10−9\nTNF signaling pathway 1.6 × 10−9\nLegionellosis 3.5 × 10−9\nRheumatoid arthritis 5.4 × 10−9\nCytokine-cytokine receptor interaction 6.6 × 10−9\nPANTHER p-Adj\nPlasminogen activating cascade 0.00156\nToll receptor signaling pathway 0.00911\nCCKR signaling map ST 0.02550\nApoptosis signaling pathway 0.10282\nBlood coagulation 0.10433\nREACTOME p-Adj\nInterferon alpha/beta signaling 1.6 × 10−9\nInterleukin-10 signaling 2.5 × 10−9\nInterleukin-4 and Interleukin-13 signaling 2.4 × 10−7\nFormation of the cornified envelope 1.3 × 10−5\nChemokine receptors bind chemokines 0.00047\nSmall Molecule Pathway DB p-Adj\nCD40L Signalling Pathway 0.25268\nNF-kB Signaling Pathway 0.25268\nToll-Like Receptor Pathway 2 0.25268\nCapecitabine Metabolism Pathway 0.25268\nCapecitabine Action Pathway 0.25268\nBIOCYC p-Adj\nvitamin D3 biosynthesis 0.03597\nguanosine nucleotides degradation 0.03597\nretinoate biosynthesis II 0.03597\nguanosine nucleotides degradation III 0.03597\nadenosine nucleotides degradation II 0.03597\nPathway Interaction DB p-Adj\nValidated transcriptional targets of AP1 family members Fra1 and Fra2 3.8 × 10−5\nIL23-mediated signaling events 0.00050\nCD40/CD40L signaling 0.02539\nGlucocorticoid receptor regulatory network 0.02603\nLPA receptor mediated events 0.04171"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1735","span":{"begin":79,"end":84},"obj":"Gene"},{"id":"1736","span":{"begin":271,"end":284},"obj":"Gene"},{"id":"1737","span":{"begin":287,"end":300},"obj":"Gene"},{"id":"1738","span":{"begin":380,"end":389},"obj":"Gene"},{"id":"1739","span":{"begin":506,"end":515},"obj":"Gene"},{"id":"1740","span":{"begin":553,"end":558},"obj":"Gene"},{"id":"1741","span":{"begin":589,"end":592},"obj":"Gene"},{"id":"1742","span":{"begin":942,"end":963},"obj":"Gene"},{"id":"1743","span":{"begin":986,"end":1000},"obj":"Gene"},{"id":"1744","span":{"begin":1023,"end":1036},"obj":"Gene"},{"id":"1745","span":{"begin":1041,"end":1055},"obj":"Gene"},{"id":"1746","span":{"begin":1205,"end":1210},"obj":"Gene"},{"id":"1747","span":{"begin":1694,"end":1698},"obj":"Gene"},{"id":"1748","span":{"begin":1703,"end":1708},"obj":"Gene"},{"id":"1749","span":{"begin":1720,"end":1724},"obj":"Gene"},{"id":"1750","span":{"begin":1760,"end":1764},"obj":"Gene"},{"id":"1751","span":{"begin":1765,"end":1770},"obj":"Gene"},{"id":"1752","span":{"begin":339,"end":352},"obj":"Gene"},{"id":"1753","span":{"begin":1561,"end":1570},"obj":"Chemical"},{"id":"1754","span":{"begin":160,"end":167},"obj":"Disease"},{"id":"1755","span":{"begin":232,"end":241},"obj":"Disease"},{"id":"1756","span":{"begin":623,"end":637},"obj":"Disease"},{"id":"1757","span":{"begin":649,"end":670},"obj":"Disease"}],"attributes":[{"id":"A1735","pred":"tao:has_database_id","subj":"1735","obj":"Gene:3606"},{"id":"A1736","pred":"tao:has_database_id","subj":"1736","obj":"Gene:5008"},{"id":"A1737","pred":"tao:has_database_id","subj":"1737","obj":"Gene:3552"},{"id":"A1738","pred":"tao:has_database_id","subj":"1738","obj":"Gene:7124"},{"id":"A1739","pred":"tao:has_database_id","subj":"1739","obj":"Gene:5617"},{"id":"A1740","pred":"tao:has_database_id","subj":"1740","obj":"Gene:3605"},{"id":"A1741","pred":"tao:has_database_id","subj":"1741","obj":"Gene:7124"},{"id":"A1742","pred":"tao:has_database_id","subj":"1742","obj":"Gene:3440"},{"id":"A1743","pred":"tao:has_database_id","subj":"1743","obj":"Gene:3586"},{"id":"A1744","pred":"tao:has_database_id","subj":"1744","obj":"Gene:3565"},{"id":"A1745","pred":"tao:has_database_id","subj":"1745","obj":"Gene:3596"},{"id":"A1746","pred":"tao:has_database_id","subj":"1746","obj":"Gene:959"},{"id":"A1747","pred":"tao:has_database_id","subj":"1747","obj":"Gene:8061"},{"id":"A1748","pred":"tao:has_database_id","subj":"1748","obj":"Gene:2355"},{"id":"A1749","pred":"tao:has_database_id","subj":"1749","obj":"Gene:51561"},{"id":"A1750","pred":"tao:has_database_id","subj":"1750","obj":"Gene:958"},{"id":"A1751","pred":"tao:has_database_id","subj":"1751","obj":"Gene:959"},{"id":"A1752","pred":"tao:has_database_id","subj":"1752","obj":"Gene:3567"},{"id":"A1753","pred":"tao:has_database_id","subj":"1753","obj":"MESH:D000241"},{"id":"A1754","pred":"tao:has_database_id","subj":"1754","obj":"MESH:D018805"},{"id":"A1755","pred":"tao:has_database_id","subj":"1755","obj":"MESH:D005355"},{"id":"A1756","pred":"tao:has_database_id","subj":"1756","obj":"MESH:D007876"},{"id":"A1757","pred":"tao:has_database_id","subj":"1757","obj":"MESH:D001172"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"WikiPathways p-Adj\nPhotodynamic therapy-induced NF-kB survival signaling 0\nIL-18 signaling pathway 8.6 × 10−9\nmiRNAs involvement in the immune response in sepsis 2.4 × 10−8\nCytokines and Inflammatory Response 9.9 × 10−7\nLung fibrosis 2.5 × 10−6\nBioPlanet p-Adj\nOncostatin M 0\nInterleukin-1 regulation of extracellular matrix 0\nInterleukin-5 regulation of apoptosis 0\nTNF-alpha effects on cytokine activity, cell motility, and apoptosis 0\nImmune system signaling by interferons, interleukins, prolactin, and growth hormones 0\nKEGG p-Adj\nIL-17 signaling pathway 1.3 × 10−9\nTNF signaling pathway 1.6 × 10−9\nLegionellosis 3.5 × 10−9\nRheumatoid arthritis 5.4 × 10−9\nCytokine-cytokine receptor interaction 6.6 × 10−9\nPANTHER p-Adj\nPlasminogen activating cascade 0.00156\nToll receptor signaling pathway 0.00911\nCCKR signaling map ST 0.02550\nApoptosis signaling pathway 0.10282\nBlood coagulation 0.10433\nREACTOME p-Adj\nInterferon alpha/beta signaling 1.6 × 10−9\nInterleukin-10 signaling 2.5 × 10−9\nInterleukin-4 and Interleukin-13 signaling 2.4 × 10−7\nFormation of the cornified envelope 1.3 × 10−5\nChemokine receptors bind chemokines 0.00047\nSmall Molecule Pathway DB p-Adj\nCD40L Signalling Pathway 0.25268\nNF-kB Signaling Pathway 0.25268\nToll-Like Receptor Pathway 2 0.25268\nCapecitabine Metabolism Pathway 0.25268\nCapecitabine Action Pathway 0.25268\nBIOCYC p-Adj\nvitamin D3 biosynthesis 0.03597\nguanosine nucleotides degradation 0.03597\nretinoate biosynthesis II 0.03597\nguanosine nucleotides degradation III 0.03597\nadenosine nucleotides degradation II 0.03597\nPathway Interaction DB p-Adj\nValidated transcriptional targets of AP1 family members Fra1 and Fra2 3.8 × 10−5\nIL23-mediated signaling events 0.00050\nCD40/CD40L signaling 0.02539\nGlucocorticoid receptor regulatory network 0.02603\nLPA receptor mediated events 0.04171"}